7 Oct 2011 14:00
7 October 2011
Phorm, Inc.
('Phorm' or the 'Company')
Block Admission Return
Phorm (AIM: PHRM and PHRX), the internet personalisation technology company, is
providing an update to its block admission return filed on 8 April 2011 (the "Scheme").
For the period from 9 April 2011 to 8 October 2011, Phorm did not issue any securities under the Scheme and has the following balance of unissued securities under the Scheme:
Name of Plan | Common Shares Originally Admitted Under The Scheme | Common Shares Issuable Under The Scheme at 8 October 2011 |
2003 Share Plan | 2,450,000 | 2,342,289 |
2009 EMI Option Plan | 250,000 | 250,000 |
TOTAL | 2,700,000 | 2,592,289 |
As of 8 October 2011, the Company had an issued share capital of 18,479,907 common shares with a par value of $0.001 each, of which 17,582,569 are trading on AIM under the ticker PHRM, the restricted line and 897,338 are trading on AIM under the ticker PHRX, the unrestricted line. A further 45,000 common shares are held in treasury.
About Phorm:
Phorm is a global personalisation technology company that makes content and
advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience. Phorm's partners include leading ISPs, Publishers, Ad Networks and Advertisers.
Phorm is a Delaware, US incorporated company, with offices in Bucharest, London Sao Paulo and Seoul. The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 150 employees and direct contractors. For more information, please visit: www.phorm.com
Enquiries:
Phorm, Inc.
Andy Croxson (analysts & investors) +44 20 7297 2326
Alex Laity (media) +44 20 7297 2710
Mirabaud Securities LLP +44 20 7321 2508
(Broker)
Jason Woollard
Peter Krens
Canaccord Genuity Limited +44 20 7050 6500
(Nominated Advisor)
Mark Williams
Andrew Chubb